Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 03:46 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Insulin Resistance in Non-alcoholic Fatty Liver Disease
NCT01289639 · VA Office of Research and Development · NA · terminated · last registry update 2017-08-17 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Low recruitment in intervention study. Baseline data published.” | – | Registry record, VA Office of Research and Development |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against PPARA within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2018-08-07Phase 3 first posted: Hanlim Pharm. Co., Ltd., HL-PIF cap.160/2mg + Placebo + Livalo tab. 2mg + Placebo (NCT03618797)
- 2018-05-07Results posted on the registry: Sanofi, Alirocumab + Placebo (NCT02584504)
- 2018-05-01Results posted on the registry: Sanofi, Alirocumab + Statins (NCT02642159)
- 2018-04-27Phase 3 first posted: Sanofi, Alirocumab SAR236553 (REGN727) + Rosuvastatin (NCT03510884)
- 2018-04-27Phase 3 first posted: Sanofi, Alirocumab SAR236553 (REGN727) + Atorvastatin (NCT03510715)
- 2018-02-06Also stopped (terminated): University of Miami, fenofibrate (NCT01142323)
- 2017-11-17Phase 3 first posted: Jaeb Center for Health Research, Pemafibrate + Placebo (NCT03345901)
- 2017-06-14Results posted on the registry: University of Miami, Fenofibrate (NCT01965834)
- 2017-06-14Also stopped (terminated): University of Miami, Fenofibrate (NCT01965834)
- 2017-06-02Results posted on the registry: The Scripps Research Institute, Sugar Pill + TRICOR (fenofibrate) (NCT02158273)
- 2017-04-20Results posted on the registry: Centre for Addiction and Mental Health, Gemfibrozil + Placebo (NCT01876810)
- 2017-03-15Results posted on the registry: Sanofi, Alirocumab + Placebo (for Alirocumab) (NCT02023879)
- 2017-03-07Phase 3 first posted: Kowa Research Institute, Inc., K-877 + Placebo (NCT03071692)
- 2017-01-05Phase 3 first posted: Kowa Research Institute, Inc., K-877 + Fenofibrate (NCT03011450)
- 2016-12-23Phase 3 first posted: Kowa Research Institute, Inc., K-877 + Fenofibrate (NCT03001817)
- 2016-10-18Phase 3 first posted: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Bezafibrate + Ursodeoxycholic Acid (NCT02937012)
- 2016-09-01Also stopped (withdrawn): Essentialis, Inc., 290 mg DCCR + 435 mg DCCR (NCT00973271)
- 2016-09-01Results posted on the registry: University of Utah, Trilipix + placebo (NCT01025492)
- 2016-09-01Also stopped (terminated): University of Utah, Trilipix + placebo (NCT01025492)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision